Cargando…
Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms res...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114478/ https://www.ncbi.nlm.nih.gov/pubmed/37072781 http://dx.doi.org/10.1186/s12933-023-01824-5 |
_version_ | 1785028023365402624 |
---|---|
author | Hrabalova, Petra Bohuslavova, Romana Matejkova, Katerina Papousek, Frantisek Sedmera, David Abaffy, Pavel Kolar, Frantisek Pavlinkova, Gabriela |
author_facet | Hrabalova, Petra Bohuslavova, Romana Matejkova, Katerina Papousek, Frantisek Sedmera, David Abaffy, Pavel Kolar, Frantisek Pavlinkova, Gabriela |
author_sort | Hrabalova, Petra |
collection | PubMed |
description | BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01824-5. |
format | Online Article Text |
id | pubmed-10114478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101144782023-04-20 Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy Hrabalova, Petra Bohuslavova, Romana Matejkova, Katerina Papousek, Frantisek Sedmera, David Abaffy, Pavel Kolar, Frantisek Pavlinkova, Gabriela Cardiovasc Diabetol Research BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01824-5. BioMed Central 2023-04-18 /pmc/articles/PMC10114478/ /pubmed/37072781 http://dx.doi.org/10.1186/s12933-023-01824-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hrabalova, Petra Bohuslavova, Romana Matejkova, Katerina Papousek, Frantisek Sedmera, David Abaffy, Pavel Kolar, Frantisek Pavlinkova, Gabriela Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
title | Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
title_full | Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
title_fullStr | Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
title_full_unstemmed | Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
title_short | Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
title_sort | dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114478/ https://www.ncbi.nlm.nih.gov/pubmed/37072781 http://dx.doi.org/10.1186/s12933-023-01824-5 |
work_keys_str_mv | AT hrabalovapetra dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT bohuslavovaromana dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT matejkovakaterina dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT papousekfrantisek dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT sedmeradavid dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT abaffypavel dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT kolarfrantisek dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy AT pavlinkovagabriela dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy |